being a common adverse event and a burden for patients with chronic kidney disease (CKD).
(4) For patients not currently treated with an erythropoiesis stimulating agent (ESA), the recommended starting dose is 0.6 microgram/kg body weight, administered once every two weeks as a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results